Castle Biosciences Inc

NASDAQ:CSTL  
33.65
-0.23 (-0.68%)
Earnings Announcements

Castle Biosciences Announces Preliminary Q4 And FY2021 Results

Published: 01/10/2022 13:01 GMT
Castle Biosciences Inc (CSTL) - Castle Biosciences Announces Preliminary Fourth Quarter and Full-year 2021 Results.
Castle Biosciences Inc - 2021 Estimated Revenue is Expected to Meet Or Exceed Top End of Guided Range of $89-93 Million.
Castle Biosciences Inc - Year-end 2021 Cash and Cash Equivalents Expected to Be Approximately $330 Million.
Revenue is expected to be $23.37 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $24.33 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.